New Amsterdam Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$10.6M |
| 2 |
Customers Bancorp
CUBI
|
+$7.74M |
| 3 |
Innospec
IOSP
|
+$7.47M |
| 4 |
PBF Energy
PBF
|
+$6.85M |
| 5 |
KNL
Knoll, Inc.
KNL
|
+$6.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$8.11M |
| 2 |
Deluxe
DLX
|
+$7.34M |
| 3 |
Avient
AVNT
|
+$5.65M |
| 4 |
INVX
Innovex International
INVX
|
+$5.34M |
| 5 |
Ziff Davis
ZD
|
+$5.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.65% |
| 2 | Industrials | 16.99% |
| 3 | Technology | 16.31% |
| 4 | Financials | 13.34% |
| 5 | Healthcare | 10.39% |
Similar funds
New Amsterdam Partners's Q2 2017 Portfolio in Review
As of Q2 2017, New Amsterdam Partners held 142 positions worth $470M, up 11% from $422M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
New Amsterdam Partners deployed $35M of net new capital in Q2 2017, opening 25 new positions and adding to 52 existing holdings. Its largest new stake was Manhattan Associates: 224,089 shares worth $10.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Innovex International, an estimated $5.34M trimmed.
- New Amsterdam Partners's largest Q2 2017 buy was Manhattan Associates: 224,089 shares worth $10.8M.
- New Amsterdam Partners added most to Innospec in Q2 2017, an estimated $7.47M increase.
- New Amsterdam Partners's biggest Q2 2017 reduction was Innovex International, cutting an estimated $5.34M.
- New Amsterdam Partners fully exited Strategy Inc in Q2 2017, selling an estimated $8.11M.
- New Amsterdam Partners's ten largest holdings make up 24% of its $470M portfolio in Q2 2017.
- New Amsterdam Partners opened 25 new positions and closed 26 in Q2 2017.
- New Amsterdam Partners's portfolio value rose 11% quarter-over-quarter to $470M.
Based on New Amsterdam Partners's 13F filing for Q2 2017, filed 2 Aug 2017.